JOHNSON & JOHNSON (JNJ)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for JNJ
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| JNJ | Distinguished Professor of Biology and Oncological Sciences, University of Utah; Chief Executive Officer Emerita, Huntsman Cancer Institute; Chair | 71 | [] | ["C","Regulatory Compliance & Sustainability Committee","Science & Technology Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Age: 71 Independent Director since 2015 Committees: Chair, Science & Technology Member, Regulatory Compliance & Sustainability Career highlights University of Utah (current) Distinguished Professor of Biology and Oncological Sciences Huntsman Cancer Institute Chief Executive Officer Emerita Other public board service Exelixis (since 2024) Huntsman Corporation (since 2011) Other affiliations Medical Advisory Board, Howard Hughes Medical Institute Board of Scientific Advisors, National Cancer Institute (2018-2022) Advisory Committee to the Director, National Institute of Health (2007-2010; 2024-2025) Director, American Association for Cancer Research (2013-2016) President, American Society for Cell Biology (2006-2007) Elected membership to National Academy of Sciences, American Philosophical Society, and American Academy of Arts and Sciences Skills & qualifications Expertise in scientific research and organizational management in the healthcare arena Active participant in national and international scientific affairs Strong focus on patient experience